ABSTRACT
Typical retinitis pigmentosa (RP) may not be the only retinal phenotype encountered in ataxia with vitamin E deficiency (AVED). The following short case series describes a novel form of retinopathy in AVED. We describe two patients with AVED belonging to the same consanguineous sibship. Both presented an unusual retinopathy consisting of scattered, multifocal, nummular, hyperautofluorescent atrophic retinal patches. The retinopathy remained stable under vitamin E supplementation. We hypothesize these changes to be the result of arrested AVED-related RP following early supplementation with α-tocopherol acetate.
Subject(s)
Retinitis Pigmentosa , Vitamin E Deficiency , Humans , Carrier Proteins/genetics , Ataxia/complications , Ataxia/genetics , Vitamin E Deficiency/complications , Vitamin E Deficiency/genetics , Retinitis Pigmentosa/complications , Retinitis Pigmentosa/genetics , Pedigree , MutationABSTRACT
Fecal incontinence (FI) is often underreported and underestimated in men. Our aims were to clarify the causes and the physiological characteristics of FI in men and to underline the differences between etiological and physiological factors in men and women diagnosed with FI. The study cohort encompassed 200 men and 200 women who underwent anatomical and physiological evaluation for FI in a tertiary referral center specializing in pelvic floor disorders. All patients underwent endoanal ultrasound and anorectal manometry. Evacuation proctography was performed in some patients. Demographic, medical, anatomical, and physiological parameters were compared between the two study groups. Urge incontinence was the most frequent type of FI in both genders. In men, anal fistula, history of anal surgeries, rectal tumors, and pelvic radiotherapy were common etiologic factors, whereas history of pelvic surgeries was more common in women. Associated urinary incontinence was reported more frequently by women. External anal sphincter defects, usually anterior, were more common in women (M: 1.5%, F: 24%, P < 0.0001), whereas internal anal sphincter defect prevalence was similar in men and women (M: 6%, F: 12%, P = 0.19). Decreased resting and squeeze pressures were less common in men (M: 29%, F: 46%, P < 0.0001: M: 44%, F: 66%, P < 0.0001). The incidence of rectal hyposensitivity was higher in men (M: 11.1%, F: 2.8%, P < 0.0001), whereas rectal hypersensitivity was higher in women (M: 5.8%, F: 10.8%, P < 0.0001). Anorectal dyssynergia was more common in men (M: 66%, F: 37%, P < 0.0001). Significantly different etiological factors and physiological characteristics for FI were found in men. Acknowledging these differences is significant and may yield better treatment options.NEW & NOTEWORTHY Fecal incontinence (FI) in men has different etiological factors when compared with women. The prevalence of internal anal sphincter defect among men with FI was similar to women. Different manometric measurements were found among men with FI: decreased anal pressures were less common among men, whereas rectal hyposensitivity and anorectal dyssynergia were more common among men.
Subject(s)
Anal Canal , Fecal Incontinence , Rectum , Female , Humans , Male , Anal Canal/pathology , Ataxia/complications , Fecal Incontinence/epidemiology , Fecal Incontinence/etiology , Manometry , Rectum/pathologyABSTRACT
A clinical scale fully dedicated to evaluating ocular motor abnormalities is required for now. We investigated the utility of a recently developed Scale for Ocular motor Disorders in Ataxia (SODA) in patients with multiple system atrophy (MSA). We prospectively assessed SODA in consecutive patients with MSA between August 2021 and August 2023 at the Korea University Medical Center. The results of the clinical exam-based SODA were compared with those measured using video-oculography (VOG-guided SODA). We also compared the findings with other established clinical scales targeting patients with MSA, including the Unified Multiple System Atrophy Rating Scale (UMSARS) I-II, Movement Disorder Society-Unified Parkinson's Disease Rating Scale motor part (UPDRS-III), Scale for Assessment of Rating of Ataxia (SARA), Composite Autonomic Symptom Score-31 (COMPASS-31), and Composite Autonomic Severity Score (CASS). Twenty patients were enrolled in our study (17 with cerebellar-type MSA and three with Parkinson-type MSA). Scores ranged from 1 to 14 (median [interquartile range (IQR)] = 8 [5-10]). Among the subscales, saccades had a median score of 2.5 (IQR = 1-3), followed by ocular pursuit (1 [0-1]), nystagmus (1 [0-2]), saccadic intrusions (1 [0-1]), vestibulo-ocular reflex (VOR) (0.5 [0-1]), ocular alignment (0 [0-1]), and VOR cancellation (1 [0-1]). The clinical-exam-based SODA (p = 0.020) and VOG-guided SODA (p = 0.034) positively correlated with disease duration. No correlation was found between clinical exam-based SODA and other scales. Skew deviation, gaze-evoked nystagmus, VOR cancellation, and smooth pursuit had the highest precision among the items. Ocular misalignment and spontaneous and positional nystagmus were frequently false positive and were poorly detected with clinical exam-based SODA. Six patients with repeated evaluation exhibited higher scores, along with deterioration documented on other clinical scales. The SODA can reliably predict neurodegeneration as an additional clinical surrogate in MSA.
Subject(s)
Ataxia , Eye Movement Measurements , Multiple System Atrophy , Ocular Motility Disorders , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Ataxia/complications , Eye Movement Measurements/standards , False Positive Reactions , Follow-Up Studies , Multiple System Atrophy/complications , Nystagmus, Physiologic , Ocular Motility Disorders/complications , Ocular Motility Disorders/diagnosis , Ocular Motility Disorders/physiopathology , Pursuit, Smooth , Reflex, Vestibulo-Ocular , Reproducibility of Results , Saccades , Sensitivity and SpecificityABSTRACT
Opsoclonus-myoclonus-ataxia syndrome (OMAS) is an autoimmune central nervous system disorder, primarily manifesting as a paraneoplastic sequalae to neuroblastoma, and characterized by motor disorders and behavioral disturbances. OMAS is typified by aberrant B-cell and T-cell activation. Current treatment involves immunosuppression using corticosteroids, intravenous immunoglobulin, and rituximab. However, these approaches often lead to treatment-related toxicities and symptomatic recurrences with chronic neurocognitive impairment. We treated three children with refractory neuroblastoma-associated OMAS with tacrolimus, a T-cell-targeting calcineurin inhibitor, effectively controlling symptoms within a month and enabling the discontinuation of immunosuppression with minimal side effects. Tacrolimus shows promise as a therapeutic option for refractory OMAS.
Subject(s)
Neuroblastoma , Ocular Motility Disorders , Opsoclonus-Myoclonus Syndrome , Child , Humans , Tacrolimus/therapeutic use , Ocular Motility Disorders/complications , Opsoclonus-Myoclonus Syndrome/drug therapy , Opsoclonus-Myoclonus Syndrome/etiology , Opsoclonus-Myoclonus Syndrome/diagnosis , Neuroblastoma/complications , Neuroblastoma/drug therapy , Neuroblastoma/diagnosis , Ataxia/complicationsABSTRACT
Paroxysmal dysarthria ataxia syndrome presents with recurrent, brief, stereotyped events of dysarthria, limb clumsiness, unsteady gait and vertigo or dizziness that can occur in association with lesions in the midbrain. We describe a case of a woman presenting with paroxysmal dysarthria and ataxia secondary to a midbrain lesion, treated successfully with carbamazepine.
Subject(s)
Ataxia , Dysarthria , Humans , Female , Dysarthria/etiology , Ataxia/complications , Ataxia/etiology , Ataxia/drug therapy , Middle Aged , Anticonvulsants/therapeutic use , Carbamazepine/therapeutic useABSTRACT
Gait disorders are a common feature of neurological disease. The gait examination is an essential part of the neurological clinical assessment, providing valuable clues to a myriad of causes. Understanding how to examine gait is not only essential for neurological diagnosis but also for treatment and prognosis. Here, we review aspects of the clinical history and examination of neurological gait to help guide gait disorder assessment. We focus particularly on how to differentiate between common gait abnormalities and highlight the characteristic features of the more prevalent neurological gait patterns such as ataxia, waddling, steppage, spastic gait, Parkinson's disease and functional gait disorders. We also offer diagnostic clues for some unusual gait presentations, such as dystonic, stiff-person and choreiform gait, along with red flags that help differentiate atypical parkinsonism from Parkinson's disease.
Subject(s)
Cerebellar Ataxia , Gait Disorders, Neurologic , Parkinson Disease , Parkinsonian Disorders , Humans , Parkinson Disease/diagnosis , Parkinsonian Disorders/complications , Gait , Cerebellar Ataxia/complications , Ataxia/complications , Gait Disorders, Neurologic/diagnosis , Gait Disorders, Neurologic/etiologySubject(s)
Cerebellar Ataxia , Cognitive Dysfunction , Dystonia , Dystonic Disorders , Humans , Sequestosome-1 Protein , Ataxia/complications , ParalysisABSTRACT
Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare immune-mediated movement disorder occurring as a paraneoplastic manifestation of neuroblastic tumours (NTs), especially neuroblastoma in infancy. Ganglioneuroma (GN), the benign tumour in the spectrum, is rarely associated with OMAS. We report the case of a child in her second year of life presenting with acute onset of progressive paraplegia and OMAS. MRI showed diffuse and infiltrating left paraspinal mass from T3-T9 levels with differentials of neuroblastoma or ganglioneuroblastoma. Histopathological and immunohistochemistry examination of the excised tumour showed maturing GN. The OMAS was managed with intravenous immunoglobulin and steroids. In the 6-month follow-up, the child has a residual motor weakness with myelomalacia in neuroimaging. The case report substantiates the occurrence of OMAS as paraneoplastic manifestation in NTs, including benign, in children younger than 2 years with a female predilection.
Subject(s)
Ganglioneuroma , Neuroblastoma , Opsoclonus-Myoclonus Syndrome , Child , Humans , Female , Opsoclonus-Myoclonus Syndrome/complications , Opsoclonus-Myoclonus Syndrome/diagnosis , Ganglioneuroma/complications , Ganglioneuroma/diagnosis , Neuroblastoma/diagnosis , Ataxia/complications , MovementABSTRACT
Subacute combined degeneration (SCD) is an acquired neurologic complication from prolonged vitamin B12 deficiency. As a result of dorsal and lateral spinal cord column degeneration, patients present with a range of neurological symptoms, including paresthesias, ataxia, and muscle weakness. Without prompt treatment, irreversible nerve damage occurs. Here we present a young man who developed progressive ascending paresthesias and lower extremity weakness after escalated nitrous oxide use. This case highlights the importance of considering SCD from nitrous oxide toxicity when patients present with progressive ataxia, paresthesia, and lower extremity weakness.
Subject(s)
Spinal Cord Diseases , Subacute Combined Degeneration , Vitamin B 12 Deficiency , Male , Humans , Nitrous Oxide/adverse effects , Paresthesia/chemically induced , Paresthesia/complications , Vitamin B 12/therapeutic use , Vitamin B 12 Deficiency/chemically induced , Vitamin B 12 Deficiency/complications , Vitamin B 12 Deficiency/diagnosis , Subacute Combined Degeneration/complications , Spinal Cord Diseases/complications , Ataxia/complicationsABSTRACT
Hereditary ataxias, especially when presenting sporadically in adulthood, present a particular diagnostic challenge owing to their great clinical and genetic heterogeneity. Currently, up to 75% of such patients remain without a genetic diagnosis. In an era of emerging disease-modifying gene-stratified therapies, the identification of causative alleles has become increasingly important. Over the past few years, the implementation of advanced bioinformatics tools and long-read sequencing has allowed the identification of a number of novel repeat expansion disorders, such as the recently described spinocerebellar ataxia 27B (SCA27B) caused by a (GAA)â¢(TTC) repeat expansion in intron 1 of the fibroblast growth factor 14 (FGF14) gene. SCA27B is rapidly gaining recognition as one of the most common forms of adult-onset hereditary ataxia, with several studies showing that it accounts for a substantial number (9-61%) of previously undiagnosed cases from different cohorts. First natural history studies and multiple reports have already outlined the progression and core phenotype of this novel disease, which consists of a late-onset slowly progressive pan-cerebellar syndrome that is frequently associated with cerebellar oculomotor signs, such as downbeat nystagmus, and episodic symptoms. Furthermore, preliminary studies in patients with SCA27B have shown promising symptomatic benefits of 4-aminopyridine, an already marketed drug. This review describes the current knowledge of the genetic and molecular basis, epidemiology, clinical features and prospective treatment strategies in SCA27B.
Subject(s)
Spinocerebellar Ataxias , Adult , Humans , Spinocerebellar Ataxias/diagnosis , Spinocerebellar Ataxias/drug therapy , Spinocerebellar Ataxias/genetics , Ataxia/complications , PhenotypeABSTRACT
INTRODUCTION: Coronavirus disease 2019 (COVID-19) can have symptoms like many neurological diseases, and one of the rare forms of these presentations is opsoclonus-myoclonus ataxia syndrome (OMAS). The pathogenesis of OMAS in adults has not been clearly elucidated and OMAS can be fatal. CASE PRESENTATION: We present a 71-year-old male patient who was admitted to the emergency department with complaints of involuntary tremor-like movements in his hands, feet and mouth, and speech impediment for three days, and was followed up with COVID-19. The patient was diagnosed with OMAS and clonazepam treatment was started. He died three days later due to respiratory arrest. Our case is the first case diagnosed with COVID-19-associated OMAS in Turkey. DISCUSSION: OMAS has no definitive treatment. Early diagnosis and initiation of corticosteroids and intravenous immunoglobulin (IVIG) therapy, if necessary, can be life-saving. In COVID-19 patients with unexplained clinical findings, awareness of different and rare diseases and a multidisciplinary approach has vital importance.
Subject(s)
COVID-19 , Ocular Motility Disorders , Opsoclonus-Myoclonus Syndrome , Aged , Humans , Male , Adrenal Cortex Hormones/therapeutic use , Ataxia/complications , COVID-19/complications , COVID-19/diagnosis , Immunoglobulins, Intravenous/therapeutic use , Ocular Motility Disorders/complications , Opsoclonus-Myoclonus Syndrome/diagnosis , Opsoclonus-Myoclonus Syndrome/drug therapy , Opsoclonus-Myoclonus Syndrome/etiologyABSTRACT
Las neuronopatías o ganglionopatías sensitivas, o enfermedades del ganglio dorsal, representan un subgrupo de enfermedades del sistema nervioso periférico, frecuentemente asociadas a trastornos disinmunes o paraneoplásicos, y a agentes tóxicos. Los pacientes típicamente presentan ataxia temprana, pérdida de los reflejos osteotendinosos y síntomas sensitivos positivos, presentes tanto en partes proximales como distales del cuerpo. Estudiamos retrospectivamente 10 casos con un diagnóstico final de neuronopatía sensitiva. El síntoma de presentación fue el de una neuropatía sensitiva de curso subagudo en todos los casos, con parestesias en el 100% de los casos. Otras manifestaciones fueron: hipoestesia (10/10), ataxia de la marcha (8/10), síntomas autonómicos (3/10) y parestesias periorales (3/10). La electrofisiología mostró un patrón de compromiso sensitivo axonal, con respuestas motoras normales. El diagnóstico final fue neuronopatía sensitiva adquirida en todos, asociada a síndrome de Sjögren en dos, a lupus eritematoso en uno, a artritis reumatoidea en uno, a cáncer en dos (paraneoplásica) e idiopática en cuatro. En los casos paraneoplásicos, los tumores fueron un carcinoma de pulmón de células pequeñas (con anticuerpos anti-Hu positivos) y un carcinoma epidermoide de pulmón. Ocho pacientes fueron tratados con inmunoterapia, con altas dosis de metilprednisolona endovenosa y/o con inmunoglobulina endovenosa; con pobre respuesta en cuatro casos, mejoría neurológica en cinco, y sin cambios en uno. El presente trabajo muestra el patrón clinico y electrofisiológico de las neuronopatías sensitivas subagudas, y la relevancia de un tratamiento temprano.
Sensory neuronopathies or ganglionopathies, or dorsal root ganglion disorders, represent a subgroup of peripheral nervous system diseases, frequently associated with dysinmune or neoplastic disorders and with toxic agents. A degeneration of both central and peripheral sensory proyections is present. Patients typically show early ataxia, loss of deep tendon reflexes and positive sensory symptoms present both in proximal and distal sites of the body. We retrospectively studied 10 cases with a final diagnosis of sensory neuronopathy. Sensory neuropathy was the presenting symptom and the course was subacute in all cases. Paresthesias in upper limbs were a predominant manifestation (100%). Other manifestations included: hypoesthesia (10/10), gait ataxia (8/10), autonomic symptoms (3/10) and perioral paresthesias (3/10). Electrophysiology showed sensory axonal neuronal pattern, with normal motor responses. Final diagnosis was acquired sensory neuronopathy in all patients, associated with Sjögren’s syndrome in 2, with lupus erythematosus in 1, with rheumatoid arthritis in 1, with a cancer in 2 (paraneoplastic) and idiopathic in 4. In paraneoplastic cases, the tumor was small cell lung cancer in 1 (with positive anti-Hu antibodies), and epidermoid lung cancer in the other. Eight patients were treated with immunotherapy, high dose intravenous methylprednisolone and/or intravenous immunoglobulin; with poor response in 4 cases, neurologic improvement in 5, and without any change in 1 patient. The present work shows the typical clinical and electrophysiological pattern of subacute sensory neuronopathy, and the relevance of early treatment.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Ataxia/diagnosis , Ataxia/drug therapy , Carcinoma, Squamous Cell/complications , Small Cell Lung Carcinoma/complications , Lung Neoplasms/complications , Paresthesia/diagnosis , Arthritis, Rheumatoid/complications , Ataxia/complications , Sjogren's Syndrome/complications , Immunoglobulins, Intravenous/therapeutic use , Fatal Outcome , Gait Ataxia/diagnosis , Gait Ataxia/drug therapy , Anti-Inflammatory Agents/therapeutic useABSTRACT
Antecedentes: El Síndrome Kinsbourne es un desorden neurológico raro caracterizado por movimientos oculares irregulares, involuntarios y multidireccionales (opsoclonos), polimioclonias difusas y ataxia. Puede ser de etiología paraneoplásica (neuroblastoma) en el 50% de pacientes, pero existen múltiples causas dentro de ellas, las para y post infecciosas. Caso clínico: Masculino de 1 año de edad, con inestabilidad de la marcha. Como único antecedente proceso respiratorio y gastrointestinal (rinorrea hialina, tos productiva así como diarrea) una semana previa al inicio del padecimiento. A la exploración física presentaba ataxia a la bipedestación que imposibilitaba la marcha. Ante la ausencia de otra sintomatología es considerado inicialmente como una cerebelitis postinfecciosa, posteriormente se agregan al cuadro clínico polimioclonias y opsoclonos, con estos datos se hace el diagnóstico de síndrome de Kinsbourne. La Imagen de resonancia magnética cerebral, electroencefalograma, citoquímica y cultivo de líquido cefalorraquídeo no mostraron alteraciones. Se realizó tomografía axial abdominal y catecolaminas en orina en busca de neuroblastoma, ambos estudios normales. Se dio manejo con prednisolona a dosis de 2 mg/kg/día. Al mes de tratamiento el paciente estaba asintomático Conclusión: el síndrome opsoclonos mioclonos es una entidad rara que debe ser considerada como diagnóstico diferencial en los casos de ataxia aguda...
Subject(s)
Humans , Male , Child, Preschool , Ataxia/complications , Opsoclonus-Myoclonus Syndrome/diagnosis , Paraneoplastic Syndromes, Nervous System/diagnosis , Clonazepam/therapeutic useABSTRACT
Fundamentos: a ataxia de Friedreich é a mais frequente das ataxias hereditárias, caracterizando-se, fundamentalmente, por um curso progressivo e elevada prevalência de comprometimento cardíaco. Resulta da síntese anormal da frataxina, proteína abundante em mitocondrias e relacionada com a produção de energia. Além de comum, o comprometimento cardíaco é uma causa frequênte de morte. Há aproximadamente dez anos, tornou-se possível o diagnóstico molecular, o que levou a uma melhor caracterização dessa enfermidade, Nesse período ocorreram também mudanças significativas nos critérios de avaliação ecocardiográfica, bem como na qualidade das imagens obtidas por esse método diagnóstico. Esses fatores podem ter levado a mudanças na prevalência das alterações ecocardiográficas encontradas na ataxia de Friedreich. Objetivo: Deteminar a prevalência das alterações ecocardiográficas, principalemnte da geometria do ventriculo esquerdo...
Subject(s)
Humans , Male , Adult , Female , Ataxia/complications , Ataxia/diagnosis , Echocardiography/methods , Echocardiography , Hypertrophy, Left Ventricular/complications , Hypertrophy, Left Ventricular/diagnosisABSTRACT
Säo relatados os aspectos clínicos de um caso de Síndrome de Miller Fisher, associado a hipofosfatemia. É feita uma revisäo de literatura
Subject(s)
Adult , Humans , Male , Ataxia/complications , Hypophosphatemia, Familial/complications , Ophthalmoplegia/complications , Parenteral Nutrition , SyndromeABSTRACT
A síndrome de Wernick e Korsakoff constitui um distúrbio cuja etiologia é uma nutricional, a nível da tiamina. Ela atinge principalmente indivíduos alcoólatras de longa data preferencialmente entre os 40 e 60 anos de idade. O quadro clínico da síndrome de Wernick é caracterizado por alteraçöes oculares, marcha atáxica e estado confusional. Na síndrome de Korsakoff registra-se a ocorryencia de alteraçöes da memória retrógrada e anterógrada e as vezes confabulaçöes. Na maior parte dos casos a síndrome de Wernicke parece constituir uma modalidade evolutivaprecedente a síndrome de Korsakoff. Os achado anátomo-patológicos demonstraram lesöes no núcleo hipotalâmico, tálamo, corpos mamilares, vérnix cerebelar superior e outras estruturas diencefálicas. As lesöes no núcleo vestibular expliicariam o nistagmo e a ataxia. Como seu prognóstico depende da precocidade do diagnóstico, é fundamental a sua determinaçäo em indivíduos considerados de risco para rápida introduçäo da terapêutica adequada
Subject(s)
Adult , Middle Aged , Humans , Alcohol Amnestic Disorder/complications , Ataxia/complications , Eye Manifestations/complications , Amnesia/complications , Thiamine DeficiencyABSTRACT
En dos de lactantes mayores con síndrome de opsoclonus mioclonus (ataxia, opsoclonus y polimioclonías), la búsqueda dirigida con métodos de laboratorio e imágenes, permitió detectar sendos ganglioneuroblastomas retroperitoneales en etapas II y III de Evans, repectivamente, uno y doce meses después del inicio de los síntomas neurológicos. Ambos fueron tratados con cirugía y quimioterapia, con regresión del sindrome neurológico y evolución posterior satisfactoria. Se han comunicado alrededor de 110 casos de opsoclonus mioclonus, 50 por ciento de ellos asociados a neuroblastoma oculto. La asociación tiene un pronóstico más favorable que el de otros neuroblastomas. Cuando se identifica el síndrome debe buscarse exhaustivamente el tumor
Subject(s)
Humans , Male , Female , Infant , Ataxia/complications , Ganglioneuroblastoma/complications , Myoclonus/complications , Ocular Motility Disorders/complications , Clinical Laboratory Techniques , Ganglioneuroblastoma/diagnosis , Ganglioneuroblastoma/drug therapy , Ganglioneuroblastoma/surgery , Neoplasms, Unknown Primary , Neurologic Manifestations , Retroperitoneal Neoplasms/drug therapy , Retroperitoneal Neoplasms/surgery , Signs and SymptomsABSTRACT
SE presentaron casos demostrativos de la Instrumentación Vertebral Segmentaria (SSI-Luque) en escoliosis neuromuscular